07 Jan 2001

Maxilase 3000 - España

Updated: 07 Jan 2001

Maxilase 3000 3000 u ceip 20 capsulas

Edemas posttraumáticos por contusiones, fracturas, luxaciones, etc. Edemas postquirúrgicos. Extracciones dentales.

Maxilase 3000 Description, Presentation and Dosage

Maxilase 3000 Description

Maxilase 3000 Drug Class Description

Enzimas antiinflamatorios

Maxilase 3000 Drug Description

CAPSULAS

Maxilase 3000 Presentation

Maxilase 3000 Presentation

Adultos: Dosis usual: 2 cápsulas 3 veces al día.

Maxilase 3000 Manufacturer

SANOFI SYNTHELABO

Related Learning Zones

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this free resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately. Content is arranged into sections with disease awareness information, mode of action videos, first-line treatment options, links to useful external hyperammonaemia content and more… 

LAL-D Knowledge Centre

LAL-D Knowledge Centre

The Lysosomal Acid Lipase (LAL) Deficiency Knowledge Centre contains a range of accurate, informative clinical content for healthcare professionals. The disease awareness section presents epidemiology, pathophysiology and diagnosis information, among others. The treatment section details the drug characteristics, safety and efficacy of sebelipase alfa – the first and only licenced treatment for LAL deficiency. The resources section contains further clinical content including a video channel presenting expert opinions on diagnostic approach and current prognosis.

Developed by EPG Health Media (Europe) Ltd for epgonline.org, in collaboration and with content provided by Alexion Pharma GmbH

Maxilase 3000 Dosage

Maxilase 3000 Precautions, Reactions and Contraindications

Maxilase 3000 Special Precautions

Related Drugs - Sistema nervioso central

Back to top